Back
NovoCure Quote, Financials, Valuation and Earnings

Global Leader In Plant Cell Biology Poised For Rapid Growth!
Click for more info and ADD THIS COMPANY TO YOUR WATCHLIST!
Buy
74
NVCR
NovoCure
Last Price:
94.18
Seasonality Move:
17.81%
7 Day Trial
ALL ACCESS PASS
$
7

Your Chance To Invest In The Green Energy Revolution!
Don't miss this one - click for more info and ADD THIS COMPANY TO YOUR WATCHLIST!NovoCure Price Quote
$94.18
-0.04 (-0.96%)
(Updated: February 4, 2023 at 4:26 AM ET)
NovoCure Key Stats
Buy
74
NovoCure (NVCR)
is a Buy
Day range:
$92.20 - $95.13
52-week range:
$56.39 - $120.03
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
18.13
P/B ratio:
22.2%
Volume:
743K
Avg. volume:
1.4M
1-year change:
35.92%
Market cap:
$9.9B
Revenue:
$535M
EPS:
$-0.77
How Much Does NovoCure Make?
Is NovoCure Growing As A Company?
NovoCure Stock Price Performance
What Is NovoCure 52-Week High & Low?
NovoCure Price To Free Cash Flow
-
Is NovoCure Stock Overvalued?
NovoCure is trading at a price to free cash flow ratio of 499.35 -
Is NovoCure Stock Undervalued?
NovoCure EV to Free Cash Flow ratio is 481.41 -
What Is NovoCure’s Price Earnings Growth Ratio?
NVCR PEG ratio is -0.66 -
Is NovoCure Trading At A Premium To Earnings?
NovoCure EV to EBIT ratio is 0.00
Is It Risky To Buy NovoCure?
Is NovoCure Cash Flow Positive?
NovoCure Return On Invested Capital
NovoCure Earnings Date & Stock Price
-
What Is NovoCure's Stock Price Today?
A single share of NVCR can be purchased today for 94.22 -
What Is NovoCure’s Stock Symbol?
NovoCure trades on the nasdaq under the ticker symbol: NVCR -
When Is NovoCure’s Next Earnings Date?
The next quarterly earnings date for NovoCure is scheduled on February 23, 2023 -
When Is NVCR's next ex-dividend date?
NovoCure's next ex-dividend date is February 4, 2023 -
How To Buy NovoCure Stock?
You can buy NovoCure shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
NovoCure Competitors
NovoCure Dividend Yield
Data Unavailable
NovoCure Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 2.77% |
Revenue: | -1.95% | -1.79% |
Analyst Recommendations
Buy Recommendations: | 2 |
---|---|
Hold Recommendations: | 3 |
Sell Recommendations: | 2 |
Price Target: | 103.75 |
Upside from Last Price: | 10.11% |